Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESSWIRE / June 12, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. ("CytomX" or the "Company") (NASDAQ:CTMX) ...
New York, New York--(Newsfile Corp. - June 11, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "Com
New York, New York--(Newsfile Corp. - June 11, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytomX Therapeutics, Inc. (NASDAQ: CTMX) a
NEW YORK, NY / ACCESSWIRE / June 11, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can rev
NEW YORK, NY / ACCESSWIRE / June 11, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities ofCytomX Therapeutics, Inc. (NASDAQ:CTMX) between May 17, 2018, and
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNK, CTMX and CLNY
01:55am, Thursday, 11'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 10, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. (“CytomX” or the “Company”) (CTMX) and certain of its officers. The class action, filed in
New York, New York--(Newsfile Corp. - June 10, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
NEW YORK, June 10, Jun 10, 2020 (GLOBE NEWSWIRE via COMTEX) --
NEW YORK, June 10, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally...
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of CytomX Therapeutics, Inc. (CTMX)
LAWSUITS FILED AGAINST BIDU, R and CTMX - Jakubowitz Law Pursues Shareholders Claims
07:10pm, Wednesday, 10'th Jun 2020
NEW YORK, NY /ACCESSWIRE / June 10, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
LOS ANGELES, CA / ACCESSWIRE / June 10, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("C
Rhumbline Advisers Sells 1,690 Shares of CytomX Therapeutics Inc (NASDAQ:CTMX)
04:20am, Wednesday, 10'th Jun 2020
Rhumbline Advisers lowered its stake in CytomX Therapeutics Inc (NASDAQ:CTMX) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CTMX, CLNY and CCL
07:30pm, Tuesday, 09'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 9, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
LOS ANGELES, CA / ACCESSWIRE / June 9, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("Cy
